Study of DCC-3014 in Combination With Avelumab in Patients With Advanced or Metastatic Sarcomas

Study of DCC-3014 in Combination With Avelumab in Patients With Advanced or Metastatic Sarcomas
Conditions:   Sarcoma;   Advanced Sarcoma;   High Grade Sarcoma
Interventions:   Drug: DCC-3014;   Drug: Avelumab
Sponsor:   Memorial Sloan Kettering Cancer Center
**RECRUITING NOW**

Source: View full study details on ClinicalTrials.gov

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. By listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.

January 28, 2020 / by / in
Comments